Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease

Rachel M. Golonka, Piu Saha, X. Beng San Yeoh, Saurabh Chattopadhyay, Andrew T. Gewirtz, Bina Joe, Matam Vijay-Kumar

Producción científica: Editorial

79 Citas (Scopus)
Idioma originalEnglish
Páginas (desde-hasta)217-221
Número de páginas5
PublicaciónPhysiological Genomics
Volumen52
N.º5
DOI
EstadoPublished - 2020

Financiación

M. Vijay-Kumar is supported by National Institutes of Health (NIH) R01Grant CA-219144. B. Joe is supported by NIH R01 Grant HL-143082. S. Chattopadhyay is supported by NIH Grant AA-026017, the Medical Research Society, and the University of Toledo College of Medicine and Life Sciences. P. Saha is supported by the Crohn’s and Colitis Foundation Research Fellowship Award 522820.

FinanciadoresNúmero del financiador
National Society of Medical Research
National Institutes of Health (NIH)HL-143082, AA-026017
National Childhood Cancer Registry – National Cancer InstituteR01CA219144
Crohn's and Colitis Foundation of America522820
University of Toledo College of Medicine and Life Sciences

    ASJC Scopus subject areas

    • Physiology
    • Genetics

    Acceder al documento

    Otros archivos y enlaces

    Huella

    Profundice en los temas de investigación de 'Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease'. En conjunto forman una huella única.
    Ver la huella completa

    Citar esto